John Mendelsohn's journey in cancer biology and therapy.
作者： Rakesh Kumar
DOI: 10.1080/15384047.2020.1712829
关键词: Cetuximab 、 Psychoanalysis 、 Cancer biology 、 Targeted therapy 、 Cancer Medicine 、 Medicine 、 Trastuzumab
摘要: This piece is a remembrance of Dr. John Mendelsohn, towering leader in cancer medicine, on the occasion his death anniversary January 7. Amongst many achievements, Mendelsohn i...
scilit.net参考文章(17)
G. H. Sato, J. Mendelsohn, J. Polikoff, J. D. Sato, A. D. Le, T. Kawamoto, Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Molecular biology & medicine. ,vol. 1, pp. 511- 529 ,(1983)
Gordon Sato, Bonnie Wolf, Tomoyuki Kawamoto, John Mendelsohn, J. Denry Sato, Hideo Masui, Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies Cancer Research. ,vol. 44, pp. 1002- 1007 ,(1984)
G N Gill, T Kawamoto, C Cochet, A Le, J D Sato, H Masui, C McLeod, J Mendelsohn, Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. Journal of Biological Chemistry. ,vol. 259, pp. 7755- 7760 ,(1984) , 10.1016/S0021-9258(17)42857-2
M J Van de Vijver, R Kumar, J Mendelsohn, Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. Journal of Biological Chemistry. ,vol. 266, pp. 7503- 7508 ,(1991) , 10.1016/S0021-9258(20)89475-7
R Kumar, H M Shepard, J Mendelsohn, Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Molecular and Cellular Biology. ,vol. 11, pp. 979- 986 ,(1991) , 10.1128/MCB.11.2.979
Joan Albanell, Larry Norton, Jose Baselga, Young Mee Kim, John Mendelsohn, Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts Cancer Research. ,vol. 58, pp. 2825- 2831 ,(1998)
J. Baselga, D. Pfister, M.R. Cooper, R. Cohen, B. Burtness, M. Bos, G. D’Andrea, A. Seidman, L. Norton, K. Gunnett, J. Falcey, V. Anderson, H. Waksal, J. Mendelsohn, Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin Journal of Clinical Oncology. ,vol. 18, pp. 904- 914 ,(2000) , 10.1200/JCO.2000.18.4.904
Rakesh Kumar, John Mendelsohn, Polypeptide growth factors in the regulation of human tumor cell proliferation Current Opinion in Oncology. ,vol. 3, pp. 70- 74 ,(1991) , 10.1097/00001622-199102000-00011
P. Carter, L. Presta, C. M. Gorman, J. B. Ridgway, D. Henner, W. L. Wong, A. M. Rowland, C. Kotts, M. E. Carver, H. M. Shepard, Humanization of an anti-p185HER2 antibody for human cancer therapy. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 4285- 4289 ,(1992) , 10.1073/PNAS.89.10.4285
T. Kawamoto, J. D. Sato, A. Le, J. Polikoff, G. H. Sato, J. Mendelsohn, Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 80, pp. 1337- 1341 ,(1983) , 10.1073/PNAS.80.5.1337